Metropolitan Life Insurance Company (MetLife)’s Centerspace CSR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,292
Closed -$73.8K 517
2024
Q1
$73.8K Sell
1,292
-42
-3% -$2.34K ﹤0.01% 1205
2023
Q4
$77.6K Buy
1,334
+2
+0.2% +$109 ﹤0.01% 1215
2023
Q3
$80.3K Buy
1,332
+58
+5% +$3.63K ﹤0.01% 1137
2023
Q2
$78.2K Sell
1,274
-8
-0.6% -$469 ﹤0.01% 1154
2023
Q1
$70K Sell
1,282
-113
-8% -$6.97K ﹤0.01% 1192
2022
Q4
$81.8K Sell
1,395
-11
-0.8% -$711 ﹤0.01% 1175
2022
Q3
$94.7K Sell
1,406
-203
-13% -$16.1K ﹤0.01% 1051
2022
Q2
$131K Sell
1,609
-198
-11% -$17.3K 0.01% 909
2022
Q1
$177K Sell
1,807
-2,701
-60% -$262K 0.01% 879
2021
Q4
$500K Sell
4,508
-409
-8% -$42.2K 0.01% 1431
2021
Q3
$465K Buy
4,917
+108
+2% +$10.2K 0.01% 1511
2021
Q2
$379K Sell
4,809
-232
-5% -$16.7K 0.01% 1700
2021
Q1
$343K Sell
5,041
-468
-8% -$33.4K 0.01% 1663
2020
Q4
$389K Buy
5,509
+3
+0.1% +$211 0.01% 1526
2020
Q3
$359K Buy
5,506
+81
+1% +$5.68K 0.01% 1433
2020
Q2
$382K Buy
5,425
+936
+21% +$59.8K 0.01% 1401
2020
Q1
$247K Sell
4,489
-311
-6% -$22.3K 0.01% 1471
2019
Q4
$348K Buy
4,800
+210
+5% +$15.7K 0.01% 1547
2019
Q3
$343K Sell
4,590
-57
-1% -$3.81K 0.01% 1526
2019
Q2
$273K Sell
4,647
-16
-0.3% -$953 ﹤0.01% 1680
2019
Q1
$279K Sell
4,663
-4
-0.1% -$232 0.01% 1672
2018
Q4
$229K Sell
4,667
-22
-0.5% -$1.18K ﹤0.01% 1722
2018
Q3
$280K Buy
4,689
+10
+0.2% +$550 ﹤0.01% 1762
2018
Q2
$259K Buy
4,679
+1,540
+49% +$83.9K ﹤0.01% 1775
2018
Q1
$163K Sell
3,139
-1,207
-28% -$63K ﹤0.01% 2025
2017
Q4
$247K Sell
4,346
-4,568
-51% -$271K ﹤0.01% 1774
2017
Q3
$545K Buy
8,914
+37
+0.4% +$2.27K ﹤0.01% 1639
2017
Q2
$551K Sell
8,877
-1
-0% -$60 ﹤0.01% 1621
2017
Q1
$526K Sell
8,878
-12
-0.1% -$772 ﹤0.01% 1612
2016
Q4
$634K Sell
8,890
-311
-3% -$19.7K ﹤0.01% 1583
2016
Q3
$547K Sell
9,201
-28
-0.3% -$1.78K ﹤0.01% 1651
2016
Q2
$597K Sell
9,229
-26
-0.3% -$1.69K ﹤0.01% 1574
2016
Q1
$672K Buy
9,255
+188
+2% +$12.3K 0.01% 1404
2015
Q4
$630K Buy
9,067
+986
+12% +$76.7K ﹤0.01% 1479
2015
Q3
$625K Sell
8,081
-458
-5% -$32.7K ﹤0.01% 1485
2015
Q2
$610K Sell
8,539
-1,170
-12% -$84.7K ﹤0.01% 1613
2015
Q1
$728K Buy
9,709
+44
+0.5% +$3.47K 0.01% 1374
2014
Q4
$790K Sell
9,665
-451
-4% -$36.7K 0.01% 1478
2014
Q3
$779K Buy
10,116
+43
+0.4% +$3.61K 0.01% 1433
2014
Q2
$928K Sell
10,073
-12
-0.1% -$1.06K 0.01% 1403
2014
Q1
$906K Buy
10,085
+7
+0.1% +$602 0.01% 1417
2013
Q4
$865K Buy
10,078
+146
+1% +$12.6K 0.01% 1429
2013
Q3
$819K Sell
9,932
-5
-0.1% -$426 0.01% 1413
2013
Q2
$855K Buy
+9,937
New +$921K 0.01% 1331

Other funds holding CSR

Metropolitan Life Insurance Company (MetLife)'s CSR Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Centerspace (CSR) in Q2 2024, closing a stake of 1,292 shares — an estimated $73.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CSR in Q2 2013 and held it in 44 quarters. The position peaked at $928K in Q2 2014. 168 funds tracked by Wall St. Rank hold CSR as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Centerspace position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,292 Centerspace shares in Q2 2024, an estimated $73.8K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Centerspace in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Centerspace position peaked at $928K in Q2 2014.
  • 168 funds tracked by Wall St. Rank held Centerspace as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.